National and Kapodistrian University of Athens
Ανίχνευση του Mycoplasma genitalium σε πληθυσμιακές ομάδες στην Ελλάδα
Abstract
dc:descriptionSUMMARYMycoplasma genitalium is the smallest member of Mycoplasmas classified as Mollicutes (referring to “soft skin” in Latin) in the phylum Tenericutes. It lacks a rigid cell wall and is resistant to beta-lactams and other antibiotics that target the cell wall. Due to its serologic cross-reactivity and morphological similarity with M. pneumoniae along with its extremely fastidious growth requirements, the study of M. genitalium became feasible after the introduction of PCR assays.M. genitalium is a sexually transmitted pathogen. In men, it has been recovered from 10- 35% and 12-41% of acute and persistent non-chlamydial non-gonococcal urethritis (NCNGU) cases respectively. It has also been associated with balanoposthitis, chronic prostatitis, acute epididymitis, proctitis, and human immunodeficiency virus (HIV) transmission. Although men infected with M. genitalium do not appear to differ significantly from those infected with C. trachomatis (with respect to sexual behavior), men infected with M. genitalium reported engaging more frequently in anal intercourse in at least one study.In women, M. genitalium has been associated with urethritis, cervicitis, endometritis, pelvic inflammatory disease, infertility, HIV infection, and adverse pregnancy outcomes. M. genitalium infections can be asymptomatic, often going undetected, while it has also been identified in the genital tract of sexually abstinent women.M. genitalium is believed to behave similarly to C. trachomatis pertaining to routes of infection and inflammatory response. Through intracellular localization and antigenic variation M. genitalium could result in treatment-resistant chronic infection.Several studies have been conducted in recent years and the reported prevalence of M. genitalium varies by geographical location and study population. In Greece, there is a lack of data pertaining the characteristics and prevalence of M. genitalium infection in high risk for sexually transmitted infections (STIs) individuals in this country. This fact and the increasing evidence of adverse sequelae associated with M. genitalium infection in men and women, prompted us to investigate the prevalence of M. genitalium and concurrently other STIs in high risk symptomatic and asymptomatic adult men, women, and licenced female sex workers (FSWs) presenting to an urban STD clinic in Athens, Greece, with a special interest in M. genitalium, its presence, epidemiological characteristics, co-infections, and risk factors.A total of 250 adults comprising 167 symptomatic individuals (87 males , 6 FSWs and 74 women non-FSWs) with symptoms pertaining to male urethritis or female cervicitis, and 83asymptomatics (7 males, 8 females seeking to exclude a sexually transmitted disease (STD) after possible exposure, and 68 FSWs updating their health certificate) were examined for a) the presence of Mycoplasma genitalium using a conventional PCR protocol targeting the V1/V3 hypervariable regions of the 16SrRNA gene as well as an MGB TaqMan Real-Time PCR assay targeting the MgPa adhesion gene, b) the presence of Chlamydia trachomatis using the Cobas Amplicor PCR platform, c) the presence of Neisseria gonorrhoeae, Mycoplasma hominis, Ureaplasma spp, Candida spp. using culture on selective media, and d) the presence of Trichomonas vaginalis using microscopy. Bacterial vaginosis was diagnosed using Amsel’s criteria. Microbiological analyses were conducted on urine specimens along with swab samples from the urethra (males) or vagina (females).Statistical evaluation was performed using descriptive techniques, mean, median, standard deviation, minimum and maximum for continuous variables and frequency tables for categorical variables. To test the association between two categorical variables the x2 test for independence was used. In the case of small sample size, results were obtained through the use of the Fisher’s exact test or simulation. Tests with p< 0.05 were considered statistically significant. All analyses were accomplished using SPSS v.24. Epidemiological, demographic and clinical data were recorded through the use of a questionnaire.The overall prevalence of STIs in the study population in descending order was: Ureaplasma spp. 39.6% (99/250), Neisseria gonorrhoeae 16.8% (42/250), Candida spp. 10.4% (26/250), Chlamydia trachomatis 10.0% (25/250), Mycoplasma hominis 9.2% (23/250), Mycoplasma genitalium 4.4% (11/250), Trichomonas vaginalis 1.2% (3/250). Bacterial vaginosis occurrence was 4.8% (12/250).The prevalence of M. genitalium among males, females non-sex workers (FNSW) and FSWs was 6.4% (6/94), 4.9% (4/82) and 1.4% (1/74) respectively. Among symptomatic males and symptomatic FNSW its prevalence was 5.7 % (5/87) and 5.4 % (4/74) respectively. M. genitalium as mono-infection was detected in three symptomatic males (3/11 or 27.3%), all with microscopic findings of urethritis. In asymptomatic individuals, the pathogen was detected in one male and in one FSW. None of the asymptomatic FNSW and none of the symptomatic FSW were infected with M. genitalium. M. genitalium was detected more frequently in swab than urine specimens.Regarding M. genitalium infection, its occurrence falls with increasing age (p=0.031). The majority of infected patients were between 20-25years old. No M. genitalium infection wasdetected in men and women aged <20 years and > 36 years. The number of M. genitalium infected persons (MGIP) who have taken antibiotics (mainly amoxicillin, with or without clavulanate) within the last 15 days was greater than that of those who have not taken antibiotics (15.8% versus 3.5%) (p=0.042). A frequency of epithelial cells in urine ≥7/hpf was observed among MGIP (p=0.014).Surprisingly, condom use was not significantly protective against acquisition of M. genitalium infection in our study (p=0.560).Co-infection rates varied among microorganisms tested, with M. genitalium more likely to be co-isolated with Ureaplasma spp. than other microorganisms tested or bacterial vaginosis occurrence (p-value of difference=0.028). After statistical exclusion of Neisseria gonorrhoeae and then Chlamydia trachomatis, the prevalence of M. genitalium among the non-gonococcal urethritis (NGU) cases and the non-gonococcal non-chlamydial urethritis (NGNCU) cases was 10.8% (4/37) και 16.7% (4/24), respectively.M. genitalium is an important microbial pathogen among patients presenting with symptoms of STI in Athens, Greece. Inclusion of M. genitalium in routine STI screening should be considered, particularly due to emerging resistance, treatment failure and concerns for lack of susceptibility of M. genitalium to doxycycline, azithromycin and recently moxifloxacin. Since its presence was variably diagnosed with either a urine specimen or urethral/cervical swab specimen, it may be necessary to routinely obtain both samples in suspected cases.FSWs did not seem to have an increased risk of STIs vs. asymptomatic at-risk non-FSW, which may be related to the successful implementation of a relevant monitoring program. This information may be useful to authorities contemplating on licensing FSWs. Future studies of licensed FSWs vs. women from the general population can better assess the differential burden of STIs in this group.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chra, Paraskevi
- Χρά, Παρασκευή
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42926